Virginia hepc monthly community of practice (cop) galleries

Browse through presentations and recordings from past COP online meetings. Click an item to see the presentation or watch the recording.

2024

SEPTEMBER 2024 PRESENTATION: Andrea Washingtonon on HCV Medication

SEPTEMBER 2024 PRESENTATION: Andrea Washingtonon on HCV Medication

JUNE 2024 PRESENTATION: VA HEPC and University of Washington HEPC Online Learning Collaboration

JUNE 2024 PRESENTATION: VA HEPC and University of Washington HEPC Online Learning Collaboration

MAY 2024 GUIDANCE: Hepatitis B Management: Primary Care Guidance

MAY 2024 GUIDANCE: Hepatitis B Management: Primary Care Guidance

APRIL 2024 ARTICLE: Community Based Point of Diagnosis HCV Treatment for Marginalized Populations

APRIL 2024 ARTICLE: Community Based Point of Diagnosis HCV Treatment for Marginalized Populations

JANUARY 2024 PRESENTATION: EJI Health, Addressing HCV among the recently incarcerated in AL

JANUARY 2024 PRESENTATION: EJI Health, Addressing HCV among the recently incarcerated in AL

2023

SEPTEMBER 2023 PRIMER: HCV Resistance Testing

SEPTEMBER 2023 PRIMER: HCV Resistance Testing

AUGUST 2023 VIDEO: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 VIDEO: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 ARTICLE: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

AUGUST 2023 ARTICLE: Integrating HCV Treatment in a CHC in a population with SUD Special Guest Susan Clapp, FNP

JULY 2023 RECORDING: Early Adherence Assessment in Minimal Monitoring

JULY 2023 RECORDING: Early Adherence Assessment in Minimal Monitoring

JULY 2023 PRESENTATION: Early Adherence Assessment in Minimal Monitoring

JULY 2023 PRESENTATION: Early Adherence Assessment in Minimal Monitoring

MAY 2023 RECORDING: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 RECORDING: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 PRESENTATION: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 PRESENTATION: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 ARTICLE: Retreatment of HCV after Treating with Direct Acting Antivirals

MAY 2023 ARTICLE: Retreatment of HCV after Treating with Direct Acting Antivirals

APRIL 2023 RECORDING: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 RECORDING: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 PRESENTATION: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 PRESENTATION: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

APRIL 2023 ARTICLE: HCV and Lymphoproliferative Disorders; Extrahepatic Manifestations

MARCH 2023 RECORDING: Occupational Exposure to HCV

MARCH 2023 RECORDING: Occupational Exposure to HCV

MARCH 2023 PRESENTATION: Occupational Exposure to HCV

MARCH 2023 PRESENTATION: Occupational Exposure to HCV

MARCH 2023 REPORT: Occupational Exposure to HCV

MARCH 2023 REPORT: Occupational Exposure to HCV

FEBRUARY 2023 RECORDING: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 RECORDING: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection

FEBRUARY 2023 ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection